clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Vitamin D May Improve Cancer Immunity by Altering the Gut Microbiome
Coronavirus
Do COVID-19 mRNA Vaccines Boost Mucosal Immunity?
Coronavirus
Pandemic Preparedness Needs Genomic Surveillance
News & Features
Walgreens Dives into Gene and Cell Therapy Delivery
News & Features
A Newly Discovered Tumor Mechanism Could Improve Immunotherapies
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Clinical drug development
News & Features
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Malorye Branca
-
April 22, 2024
0
News & Features
Enhertu Becomes First Tumor Agnostic HER2-Targeted Treatment Approved
Malorye Branca
-
April 8, 2024
0
News & Features
Investigational mRNA-Based Vaccine May Represent New Approach to Treating Pancreatic Cancer
Chris Anderson
-
April 8, 2024
0
Coronavirus
CureVac Announces Positive Phase II Data For mRNA Flu Vaccine
Helen Albert
-
April 5, 2024
0
News & Features
Gilead and Xilio Ink Potential $640M+ Deal around “Next-Generation” Immunotherapy
Malorye Branca
-
April 3, 2024
0
News & Features
Improving Gene Therapy Development for Rare Diseases
Kathy Vuksanaj
-
April 1, 2024
0
News & Features
Creating Transformational Medicines
Damian Doherty
-
April 1, 2024
0
News & Features
Merck’s First-in-Class Drug for Pulmonary Arterial Hypertension Approved by the FDA
Chris Anderson
-
March 27, 2024
0
Coronavirus
NIH Launches Trials to Evaluate Best Treatments for Autonomic Nervous System Dysfunction Related to Long COVID
Chris Anderson
-
March 13, 2024
0
News & Features
Combo Therapy Approved for HER2-Positive Breast Cancer Effective against Other Cancer Types
Chris Anderson
-
March 4, 2024
0
1
2
3
...
16
Page 1 of 16
Related Content
hC Bioscience Will Target Hemophilia A with Modified tRNA Therapy
Weight Loss Drugs Linked to Lower Rate of Multiple Sclerosis
Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes
Scandinavian Study Clears GLP-1 Agonists of Thyroid Cancer Risk
Inside Precision Medicine
![Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. [Visual Mozart/Getty Images]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1628-768x794.jpeg "Metsera Launches with $290M to Develop Next Generation Weight Loss Products")
